Mizutani Haruo, Hori Tetsuya, Takahashi Tomoyuki
Department of Neurophysiology, University of Tokyo Graduate School of Medicine, Tokyo 113-0033, Japan.
Eur J Neurosci. 2006 Oct;24(7):1946-54. doi: 10.1111/j.1460-9568.2006.05063.x.
5-hydroxytryptamine (5-HT) inhibits transmitter release via activating GTP-binding proteins, but the target of 5-HT receptors in the nerve terminal is not determined. We addressed this question at the calyx of Held synapse in the brainstem slice of immature rats. Bath-application of 5-HT attenuated the amplitude of nerve-evoked excitatory postsynaptic currents (EPSCs) associated with an increase in the paired-pulse ratio, whereas it had no effect on the amplitude of spontaneous miniature EPSCs. The 5-HT1B receptor agonist CP93129 mimicked the inhibitory effect of 5-HT, but the 5-HT1A agonist (R)-(+)-8-hydroxy-DPAT (8-OHDPAT) had no effect. The 5-HT1B receptor antagonist NAS-181 blocked the inhibitory effect of 5-HT. These results suggest that 5-HT activated 5-HT1B receptors in calyceal nerve terminals, thereby inhibiting transmitter release. In direct whole-cell recordings from calyceal nerve terminals, 5-HT attenuated voltage-dependent Ca2+ currents, but had no effect on voltage-dependent K+ currents. When EPSCs were evoked by presynaptic Ca2+ currents during simultaneous pre- and postsynaptic recordings, the magnitude of the 5-HT-induced inhibition of Ca2+ currents fully explained that of EPSCs. Upon repetitive applications, 5-HT showed tachyphylaxis, with its effect on both EPSCs and presynaptic Ca2+ currents becoming weaker in the second application. 1,2-bis(o-aminophenoxy)ethane-N-N'-N'-N'-tetraacetic acid (BAPTA; 10 mm) loaded into the nerve terminal abolished this tachyphylaxis. The presynaptic inhibitory effect of 5-HT was prominent at postnatal day 5, but became weaker as animals matured. We conclude that activation of 5-HT1B receptors inhibits voltage-gated Ca2+ channels, thereby inhibiting transmitter release at immature calyceal nerve terminals, and that 5-HT1B receptors undergo Ca2+-dependent tachyphylaxis on repetitive activations.
5-羟色胺(5-HT)通过激活GTP结合蛋白来抑制神经递质释放,但5-HT受体在神经末梢的作用靶点尚未明确。我们在未成熟大鼠脑干切片中的Held壶腹突触处探讨了这个问题。浴加5-HT可使神经诱发的兴奋性突触后电流(EPSCs)幅度减弱,并伴有成对脉冲比率增加,而对自发微小EPSCs的幅度无影响。5-HT1B受体激动剂CP93129模拟了5-HT的抑制作用,但5-HT1A激动剂(R)-(+)-8-羟基二丙胺基四氢萘(8-OHDPAT)则无此作用。5-HT1B受体拮抗剂NAS-181可阻断5-HT的抑制作用。这些结果表明,5-HT激活了壶腹神经末梢中的5-HT1B受体,从而抑制神经递质释放。在对壶腹神经末梢进行直接全细胞记录时,5-HT可减弱电压依赖性Ca2+电流,但对电压依赖性K+电流无影响。当在突触前和突触后同时记录时,由突触前Ca2+电流诱发EPSCs时,5-HT对Ca2+电流的抑制幅度完全解释了其对EPSCs的抑制作用。重复应用时,5-HT出现快速耐受性,其对EPSCs和突触前Ca2+电流的作用在第二次应用时均变弱。将1,2-双(邻氨基苯氧基)乙烷-N,N,N',N'-四乙酸(BAPTA;10 mM)注入神经末梢可消除这种快速耐受性。5-HT的突触前抑制作用在出生后第5天很明显,但随着动物成熟而减弱。我们得出结论,5-HT1B受体的激活抑制电压门控Ca2+通道,从而在未成熟的壶腹神经末梢抑制神经递质释放,并且5-HT1B受体在重复激活时会发生Ca2+依赖性快速耐受性。